User banner image
User avatar
  • admin

Posts

Brink’s Announces Fourth-Quarter and Full-Year 2025 Results

Fourth quarter revenue growth of 9% with organic growth of 5% Accelerating AMS/DRS fourth quarter organic growth to 22%Record 2025 cash generation with cash from operations...

Zscaler Announces Strong Second-Quarter Fiscal 2026 Results; Raises Fiscal 2026 ARR Guidance to 24%

Exceeds high-end of second-quarter guidance on revenue and profitability metrics Second Quarter Highlights Revenue grew 26% year-over-year to $815.8 million Annual Recurring Revenue (“ARR”) grew...

Fast Company Grill Returns to SXSW Featuring CEOs of Yahoo, Rivian, Roku, PepsiCo, and Founders of Ben & Jerry’s, Goodles, and More

Register Now to Join Four Days of Insight, Innovation, and Networking With Today’s Most Influential Brands Austin, TX, Feb. 26, 2026 (GLOBE NEWSWIRE) — Fast...

SkinnyRx GLP-1 Weight Loss 2026: Compounded Semaglutide and Tirzepatide Program, Pricing, and FDA Regulatory Status Examined

Examining SkinnyRx’s Compounded GLP-1 Weight Loss Platform for 2026: Semaglutide and Tirzepatide Medication Formats, Subscription Pricing From $199 Per Month, 503A Pharmacy Sourcing, Clinical Research...

Anteris Reports 2025 Financial Results and Provides Corporate Update

MINNEAPOLIS and BRISBANE, Australia, Feb. 26, 2026 (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR), a global structural...

Sprout Health NAD+ Injections — Compounding Status, Pharmacy Sourcing, and What Consumers Should Verify Before Any Telehealth NAD+ Enrollment in 2026

Compounded NAD+ Telehealth Access, FDA Classification, Pharmacy Sourcing Standards, Prescription Requirements, and Consumer Verification Steps for Evaluating Any NAD+ Injection Program in 2026 Encinitas, CA,...

MacroGenics to Participate in Upcoming Investor Conferences

ROCKVILLE, MD, Feb. 26, 2026 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer,...

Extendicare Announces 2025 Fourth Quarter and Full Year Results and Dividend Increase

MARKHAM, Ontario, Feb. 26, 2026 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months...

Netflix Declines to Raise Offer for Warner Bros.

HOLLYWOOD, Calif., Feb. 27, 2026 /PRNewswire/ — Netflix, Inc. today announced that it has declined to raise its offer for Warner Bros. Netflix had earlier...

Jacobi Launches Suite of AI-Assisted Coding Resources to Accelerate Custom Investment Technology Development

BRISBANE, Australia, Feb. 27, 2026 /PRNewswire/ — Jacobi Strategies (Jacobi), a global leader in investment technology, today announced the launch of its AI-Assisted Coding Resources,...